Allspring Global Investments
VYGR icon

Allspring Global Investments’s Voyager Therapeutics VYGR Stock Holding History

Allspring Global Investments’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Buy
71,050
+2,220
+3% +$8.42K ﹤0.01% 1614
2026
Q1 		$266K Buy
68,830
+7,055
+11% +$27.8K ﹤0.01% 1552
2025
Q4 		$249K Buy
61,775
+5,422
+10% +$24K ﹤0.01% 1547
2025
Q3 		$263K Sell
56,353
-557
-1% -$2.02K ﹤0.01% 1508
2025
Q2 		$177K Sell
56,910
-3,552
-6% -$11.5K ﹤0.01% 1554
2025
Q1 		$204K Buy
60,462
+21,149
+54% +$98.8K ﹤0.01% 1655
2024
Q4 		$223K Buy
39,313
+7,573
+24% +$48.8K ﹤0.01% 1656
2024
Q3 		$186K Sell
31,740
-63,034
-67% -$458K ﹤0.01% 1687
2024
Q2 		$750K Sell
94,774
-4,532
-5% -$38K ﹤0.01% 1407
2024
Q1 		$925K Buy
99,306
+2,030
+2% +$17.1K ﹤0.01% 1387
2023
Q4 		$821K Buy
97,276
+20,916
+27% +$152K ﹤0.01% 1388
2023
Q3 		$592K Buy
+76,360
New +$697K ﹤0.01% 1491

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Allspring Global Investments's VYGR Position: Q2 2026 in Review

Allspring Global Investments increased its Voyager Therapeutics (VYGR) stake by 3.2% in Q2 2026, buying an estimated $8.42K and bringing the position to 71,050 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #1614.

Allspring Global Investments first reported a position in VYGR in Q3 2023 and has held it in 12 quarters since. The position peaked at $925K in Q1 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Allspring Global Investments held 71,050 shares of Voyager Therapeutics worth $249K as of Q2 2026.
  • Allspring Global Investments bought 2,220 Voyager Therapeutics shares in Q2 2026, an estimated $8.42K.
  • Voyager Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1614 holding.
  • Allspring Global Investments first reported a position in Voyager Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • Allspring Global Investments's Voyager Therapeutics position peaked at $925K in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.